1. Mechanisms Underlying Vascular Endothelial Growth Factor Receptor Inhibition–Induced Hypertension: The HYPAZ Trial. Issue 5 (29th March 2021) Authors: Mäki-Petäjä, Kaisa M.; McGeoch, Adam; Yang, Lucy L.; Hubsch, Annette; McEniery, Carmel M.; Meyer, Paul A.R.; Mir, Fraz; Gajendragadkar, Parag; Ramenatte, Nicola; Anandappa, Gayathri; Santos Franco, Sara; Bond, Simon J.; Schönlieb, Carola-Bibiane; Boink, Yoeri; Brune, Christoph; Wilkinson, Ian B.;... Journal: Hypertension Issue: Volume 77:Issue 5(2021) Page Start: 1591 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 132 Investigating the lowest threshold of vascular benefits from LDL lowering with a PCSK9 inhibitor in healthy volunteers – results from the intensity-low study. (17th July 2020) Authors: Cacciottolo, Paul; Kostapanos, Michalis S; Pavey, Holly; Hubsch, Annette; Wilkinson, Ian B; Cheriyan, Joseph Journal: Heart Issue: Volume 106(2020)Supplement 2 Page Start: A109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Low-dose interleukin 2 for the reduction of vascular inflammation in acute coronary syndromes (IVORY): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase II clinical trial. Issue 10 (7th October 2022) Authors: Sriranjan, Rouchelle; Zhao, Tian Xiao; Tarkin, Jason; Hubsch, Annette; Helmy, Joanna; Vamvaka, Evangelia; Jalaludeen, Navazh; Bond, Simon; Hoole, Stephen P; Knott, Philip; Buckenham, Samantha; Warnes, Victoria; Bird, Nick; Cheow, Heok; Templin, Heike; Cacciottolo, Paul; Rudd, James H F; Mallat, Z... Journal: BMJ open Issue: Volume 12:Issue 10(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase I/II clinical trial. Issue 9 (17th September 2018) Authors: Zhao, Tian Xiao; Kostapanos, Michalis; Griffiths, Charmaine; Arbon, Emma L; Hubsch, Annette; Kaloyirou, Fotini; Helmy, Joanna; Hoole, Stephen P; Rudd, James H F; Wood, Graham; Burling, Keith; Bond, Simon; Cheriyan, Joseph; Mallat, Ziad Journal: BMJ open Issue: Volume 8:Issue 9(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. GLP‐1 Is a Coronary Artery Vasodilator in Humans. Issue 22 (20th November 2018) Authors: Clarke, Sophie J.; Giblett, Joel P.; Yang, Lucy L.; Hubsch, Annette; Zhao, Tian; Aetesam‐ur‐Rahman, Muhammad; West, Nick E. J.; O'Sullivan, Michael; Figg, Nichola; Bennett, Martin; Wewer Albrechtsen, Nicolai J.; Deacon, Carolyn F.; Cheriyan, Joseph; Hoole, Stephen P. Journal: Journal of the American Heart Association Issue: Volume 7:Issue 22(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Investigating the Lowest Threshold of Vascular Benefits from LDL Cholesterol Lowering with a PCSK9 mAb Inhibitor (Alirocumab) in Patients with Stable Cardiovascular Disease (INTENSITY-HIGH): protocol and study rationale for a randomised, open label, parallel group, mechanistic study. Issue 4 (13th April 2021) Authors: Cacciottolo, Paul J; Kostapanos, Michalis S; Hernan Sancho, Elena; Pavey, Holly; Kaloyirou, Fotini; Vamvaka, Evangelia; Helmy, Joanna; Hubsch, Annette; McEniery, Carmel M; Wilkinson, Ian B; Cheriyan, Joseph Journal: BMJ open Issue: Volume 11:Issue 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Investigating the lowest threshold of vascular benefits from LDL cholesterol lowering with a PCSK9 mAb inhibitor (alirocumab) in healthy volunteers – a mechanistic physiological study (INTENSITY-LOW): protocol and study rationale. (1st January 2019) Authors: Kostapanos, Michael S.; Cacciottolo, Paul J.; Hubsch, Annette; Pavey, Holly; Hurlock, James; Maki-Petaja, Kaisa; Wilkinson, Ian B.; Cheriyan, Joseph Journal: Journal of drug assessment Issue: Volume 8(2019)Supplement 1 Page Start: 167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗